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Abstract
Background: The number of racial/ethnic minority children will exceed the number of white children in the USA
by 2018. Although 38% of Americans are minorities, only 12% of pediatricians, 5% of medical-school faculty, and 3%
of medical-school professors are minorities. Furthermore, only 5% of all R01 applications for National Institutes of
Health grants are from African-American, Latino, and American Indian investigators. Prompted by the persistent lack
of diversity in the pediatric and biomedical research workforces, the Academic Pediatric Association Research in
Academic Pediatrics Initiative on Diversity (RAPID) was initiated in 2012. RAPID targets applicants who are members
of an underrepresented minority group (URM), disabled, or from a socially, culturally, economically, or educationally
disadvantaged background. The program, which consists of both a research project and career and leadership
development activities, includes an annual career-development and leadership conference which is open to any
resident, fellow, or junior faculty member from an URM, disabled, or disadvantaged background who is interested
in a career in academic general pediatrics.
Methods: As part of the annual RAPID conference, a Hot Topic Session is held in which the young investigators
spend several hours developing a list of hot topics on the most useful faculty and career-development issues. These
hot topics are then posed in the form of six “burning questions” to the RAPID National Advisory Committee
(comprised of accomplished, nationally recognized senior investigators who are seasoned mentors), the RAPID
Director and Co-Director, and the keynote speaker.
Results/conclusions: The six compelling questions posed by the 10 young investigators—along with the
responses of the senior conference leadership—provide a unique resource and “survival guide” for ensuring the
academic success and optimal career development of young investigators in academic pediatrics from diverse
backgrounds. A rich conversation ensued on the topics addressed, consisting of negotiating for protected research
time, career trajectories as academic institutions move away from an emphasis on tenure-track positions, how
“non-academic” products fit into career development, racism and discrimination in academic medicine and how to
address them, coping with isolation as a minority faculty member, and how best to mentor the next generation of
academic physicians.
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Background
Recent US Census data document that racial/ethnic
minorities comprise the majority of the population in
370 US counties and the District of Columbia, and that
the population growth of Latinos, Asians, and African-
Americans is far outpacing that of whites in America [1].
Projections indicate that the number of minority
children will exceed the number of white children in the
US by 2018 [2]. Nevertheless, although 38% of
Americans are minorities [3], only 12% of US pediatri-
cians [4], 5% of US medical-school faculty [5], and 3% of
US medical-school professors [5] are minorities. Further-
more, only 5% of all R01 applications for National
Institutes of Health (NIH) grants are from African-A-
merican, Latino, and American Indian investigators, and
African-American investigators are significantly less
likely than white investigators to be awarded an NIH
R01 (Research Project Grant), even after adjustment for
relevant covariates [6].
Prompted by the persistent lack of diversity in the
pediatric and biomedical research workforces, the
Academic Pediatric Association (APA) Research in
Academic Pediatrics Initiative on Diversity (RAPID) was
initiated in 2012, with support from a Professional
Society Programs to Promote Diversity (R25) grant from
the National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK). RAPID targets applicants
who are members of an underrepresented minority
group (URM), disabled, or from a socially, culturally,
economically, or educationally disadvantaged back-
ground. The program, which includes both a research
project and career and leadership development activities,
consists of: 1) small research grants in NIDDK mission
areas (pediatric obesity, nutrition, and/or sickle cell
disease); 2) pairing of the RAPID scholar with a national
mentor who is an accomplished senior investigator and
seasoned mentor; 3) RAPID Scholar telephone confer-
ence calls every two months, to provide peer support,
peer mentoring, networking, a venue for presenting
research in progress, and opportunities for potential
research collaborations; 4) in-person mentoring and
networking at an annual breakfast at the Pediatric
Academic Societies (PAS) meeting; and 5) an annual fall
conference on career development, leadership, and
academic success which is open to any resident, fellow,
or junior faculty member from an URM, disabled, or dis-
advantaged background who is interested in pursuing an
academic career in general pediatrics [7].
The aim of this paper is to identify hot topics, urgent
priorities, and how to ensure success for racial/ethnic
minority young investigators in academic pediatrics,
based on a special session which occurred at the 2015
RAPID Conference. No previous published work, to our
knowledge, has ever addressed these issues using the
innovative approach of having young investigators iden-
tify such “hot topics,” and then addressing these critical
issues by posing questions to a panel of nationally re-
nowned senior academicians from diverse backgrounds.
Methods
As part of the annual RAPID fall conference, a Hot
Topic Session is held in which the young investigators
spend several hours developing a list of hot topics on
the most useful faculty and career-development issues.
These hot topics are then posed in the form of six
“burning questions” to the RAPID National Advisory
Committee (comprised of eight accomplished, nationally
recognized senior investigators who are seasoned
mentors, three of whom attended the conference, and
two of whom were present for the panel), the RAPID
Director (GF) and Co-Director (FSM), and the keynote
speaker (LP).
The 10 young investigators who attended the 2015
RAPID fall conference hailed from institutions across
the US and included the two 2015 RAPID Scholars (JE,
CF), five assistant professors, two fellows, and one chief
resident, of whom seven are African-American and three
are Latino. The six compelling questions posed by these
young investigators—along with the responses of the
senior conference leadership—provide a unique resource
and “survival guide” for ensuring the academic success
and optimal career development of young investigators
in academic medicine from diverse backgrounds.
Results: dialogue and discussion
Topics identified by the young investigators and
addressed the senior conference leadership include ne-
gotiating for protected research time, career trajectories
as academic institutions move away from an emphasis
on tenure-track positions, how “non-academic” products
fit into career development, racism and discrimination
in academic medicine and how to address them, coping
with isolation as a minority faculty member, and how
best to mentor the next generation of academic physi-
cians. The text that follows is a verbatim transcript of
the session held during the 2015 RAPID fall conference
(with minor editing for clarity and brevity).
Negotiating for protected research time
Mikah Owen: How do we negotiate for more protected
research time in our jobs for whatever area of interest
we may have?
Jason Mendoza (JM): When you’re negotiating in
general, just remember to negotiate. Remember to let
them know what you want, because one of the things,
especially when you negotiate with your own institution,
is that you forget that they may not have your best inter-
ests at heart. They have to look out for their division or
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department, and so you need to really set out, “this is
what I need and this is why.” Have protected research
time, a timeline for your K [NIH mentored career-
development award], people who are going to be your
mentors on board and who can back you up in other
conversations. It’s a negotiation, and you need to put out
really concrete steps so that the division head can
picture your progress, see where you’re going. And the
timeline which you’ll get, it’s usually, hopefully, within
two years of you getting there to include time for K
revision and resubmission. I think just having that laid
out for them will be good.
Elena Fuentes-Afflick (EFA): Having seen both sides
of this issue, being intentional about it, as Jay [Mendoza]
is mentioning, is really important. There are some really
helpful books about negotiation and I would encourage
you to read them. It’s a mistake to say, “I want this, I
want that, etc.” As Jay’s mentioned, you have to under-
stand the context of your colleagues within the division
and department. It’s fine to advocate for yourself, but
remember that there are other factors, it’s not just a
one-off kind of decision. And also try to think about the
person from whom you’re making the ask. What are the
things that they want in terms of success, their division,
for your clinic, for your department? How can you speak
the language that they want to hear, and somehow, by
them helping you, you are helping them, and then it can
become a virtuous cycle where, yes, it’s an investment,
but the return is helping them advance another kind of
agenda. And those are examples of the kinds of tips that
you can learn from books. There’s, of course, Getting to
Yes, and other ones. There are also workshops that you
can attend. I keep plugging PAS workshops, but there
are some really helpful little tips that you can incorpor-
ate. I encourage you to rehearse, because Glenn [Flores]
was making the point about the common use of “um”
and “ah.” The more that you stumble over something
that you’re saying, it communicates to the other person,
“I’m feeling uncomfortable about this, that’s why it’s hard
for me to get it out.” But if you rehearse, it won’t come
across too strong, because an ultimatum is unlikely to
help you. If you’re going to make an ultimatum, be sure
that you are ready to follow through, and very rarely will
you be ready to do that. Make sure to speak in a respect-
ful and constructive way, but it’s fine to advocate and
self-promote, just don’t come across too strong, and
sometimes, rehearsing with a colleague or your mentor
can really help you with that.
Glenn Flores (GF): Address two key issues: one is
logic and the other is return on investment. Explain to
your supervisor why it’s important for you to have the
protected time. For example, you could say, “I need to
develop my research portfolio, and this will reflect well
on the division and department if I get publications and
grants.” The return on investment is those products.
There was a time when any kind of clinician-investigator
position was a standard of at least three years of 50–75%
protected time for research, along with research seed
funds. Those days seem to be either gone or going by
the wayside at a lot of institutions, so you have to get an
idea of what’s the pulse at the institution that you’re
thinking about, because there are some institutions
where you have to come out of your fellowship with a K
Award already in hand. Unfortunately, a lot of
institutions are moving in that direction, so that is a
whole another structured way of thinking. So that’s a
third key issue: assess the pulse regarding what’s the
industry standard at your institution, and then you’ll be
in good shape.
Fernando Mendoza (FM): I would just add the issue
of “show me.” As a division chief, I don’t know every-
thing everybody does. You need to come with the pres-
entation, “let me show you what I’ve done and what I’ve
accomplished, and here’s what I need to continue this
work. When you do negotiate, it may not be a one-time
process, but rather, you should be ready to come back
and say, “you gave me the opportunity to do research
and I got this research project done, I got this paper
published,” etc., “so now I would like continued support
for X.” At the end of the day, the negotiation that every-
body talks about is really relationship building, and that
relationship has to be based on trust, and the trust has
to be based on positive outcomes, outcomes that people
want done. If I support research time, and nothing hap-
pens, then when they comes back to me again and say
they want more research time, I’m going to have to say,
“well, what happened last time?” So, think about negoti-
ations at any level as trying to create the relationship of
trust, positive outcomes, and adding to what your chief
wants and what you want.
JM: Can I just add one thing? If you’re considering
more than one institution, it can be helpful to let them
know about that. When people are competing for you, it
can give you a little bit of leverage and actually show
how you’re valued outside of just one institution.
GF: Four of the five of us [on the panel] have been or
are division chiefs, and I don’t know if Lee wants to
weigh in on this, but you have to understand what’s go-
ing on in the mind of the person you’re asking for the
protected time. These days, it’s a combination of making
sure you’re maximizing RVUs [relative value units, a
metric for value used in US Medicare reimbursement
formulae for physician services and procedures], making
sure you’re getting all the teaching done that you’re sup-
posed to get done, and keeping your department chair
happy, who’s usually pressuring you to get those RVUs.
And now, we’re seeing that increase. What even consti-
tutes a full-time clinician is up for debate, because it
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used to be 80% clinical effort, and then you have the one
day of administrative time, but now, we’re seeing
institutions requiring 90% or even 100% clinical effort,
so it’s starting to evolve into a completely different land-
scape, and it’s important for you to understand the
different pressures and dimensions.
Career trajectories as academic institutions move away
from emphasizing tenure
Kymberly Gonzalez: In an environment moving away
from the typical tenure track, how will our careers be
different than the environment before?
EFA: I’m going to try to answer wearing my academic
affairs hat, because I interact with faculty who are basic
scientists, clinicians, everyone, and I think that we have
mythologized what an academic career used to be in
terms of the benchmark that we’re using for compari-
sons. There’s no question that as money has become
tighter, there are new realities, but I think that the past
was not quite as rosy as we think it was, and now we
have to demonstrate our contributions in all mission
areas, which means that you need to consider your clin-
ical contributions, education, scholarship, and service.
As we look to the future, I believe we’re going to see
some new structures. We’re going to be less departmen-
tally or divisionally restricted, because we’ve had very
strong silos between our organizational units. I think
those are going to change, but that’s going to take a
while to change, especially the departmental ones. We’re
very wed to our departments. If you’re a generalist, by
definition, some of those criteria don’t adequately repre-
sent our clinical value, so I think we have the opportun-
ity to define value on our own terms. Institutions are
rooted in history and it’s going to take a while, but we
need to look at the future as an opportunity to define
ourselves and our rules in ways that we want to define,
rather than fitting into the existing structure. We’ve
been discussing tenure, what it means and whether we
should we have it. That conversation will last another
20 years and will undoubtedly affect all of you, depend-
ing upon what kind of career path you choose. The
other elements of academic life will remain largely in
place, but I still think it’s important for you to decide
how you want to add value to your institution and how
you want to define value.
Lee Pachter (LP): Each institution is very different.
I’ve never been on a tenure track in my whole career. If
you’re working at an institution which is actually a med-
ical school, tenure track is an important thing, but when
I was in Connecticut, I was working at a teaching hos-
pital, so my payor was actually the hospital, and not the
university, so tenure was not an issue. Then, when I
came to St. Christopher’s, I’m a Drexel faculty member,
but Drexel doesn’t pay me, St. Christopher’s pays me, so
I’ve never been on a tenure track, and I think that there
are some traditional institutions where tenure is really
important. But for many of the places that you’re going
to be looking for positions, tenure isn’t even going to be
an issue.
GF: I would add that tenure is not what it used to be.
Customarily, based on the traditional European system,
it was supposed to allow you liberty to pursue intellec-
tual interests and the security to do so. Now, it’s such a
rare bird in the US. Some institutions have abolished it.
At a lot of institutions, you can get tenure, but in some
senses, it’s meaningless. For example, I know of at least
one institution where you get tenure, but you have an
annual contract that gets renewed, and so, theoretically,
you could either be let go, or you could be put into a
traditional university position (instead of a school of
medicine position) where your salary would be severely
cut. Thus, there are a lot of ways that institutions can
“extract” you from their faculty, if they want to, so it
doesn’t have the same meaning that it used to. Now, on
the flip side, there are still institutions where it’s an up-
or-out situation where you have to get promoted to the
next level, or you’re gone or get knocked down to a pos-
ition that you wouldn’t want to be knocked down to. So
you really have to be aware if you’re applying for a job in
which one of those systems is in place. But it really is no
longer, in most cases, a situation where you’re there for
life and you don’t have to worry. Even in places where
there’s more security, there still is tenure review, in
which the chair sends a letter to your dean stating
whether you are “where you should be.” So, I just
wanted to open your eyes, because I had to learn that in
the past few years, and it’s a constantly shifting changing
landscape.
FM: I would add that what you’re hearing is the effect
of money. And one of the things you ought to do is look
at your institution and see how the money flows. Many
institutions have gotten rid of tenure because that was a
contract that made them pay salaries for people that
may not be achieving the expected productivity. More
and more, I think it’s more difficult to get tenured, be-
cause you have to be able to show that you can be pro-
ductive in grant writing, and supporting your salary.
Now that getting NIH grants is more difficult, schools
are reluctant to invest in that area without some assur-
ance. So, in general, most schools will have three aca-
demic lines. One is a “tenure line,” which usually means
that you are primarily doing about 80% research, and
the assumption is you’re going to be able to support
yourself from grants. The second line is the clinical
scholar. You do clinical work that can range from 50 to
80%, along with 20–50% research. And then the clinician
line or educator line, in which you primarily see patients,
teach, and you may do some scholarship. There’s
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variability within these lines among schools, depending
on what their traditions are with respect to faculty lines,
and how much money they have to support scholarship.
This is not to scare you, just to make you aware about
faculty lines.
GF: I’ll add one thing that didn’t occur to me until a
little bit later in my career, which is probably more
meaningful now if you can get it, and that depends on
you, obviously, being highly productive and well-
recognized: an endowed professorship or endowed chair.
I imagine a lot of you don’t necessarily understand what
that is, but it is essentially a donor makes a big contribu-
tion, let’s say it’s a million dollars. You then get the inter-
est from the principal every year. So if it’s for a million
dollars, at a typical 5% return on the interest, that’s
$50,000 a year. There are even bigger endowed profes-
sorships and distinguished chairs. So that’s, for me, the
Holy Grail: when you get one of those, you have this
nice money to play with and you can use it for essen-
tially anything that’s research related. You can use it for
trainees, your own research, or a statistician, so it’s really
nice, it’s something eventually to think about, but at the
beginning of your career, you may not even be aware of
it, other than thinking it’s an honorific.
FM: People often use that for their salaries, too.
GF: That’s the other good thing. You could support
your salary with an endowment so that you don’t have
to be in clinic.
How “non-academic” products fit into career
development
Nicole Brown: We were interested in your thoughts
about nonacademic products, like op-ed pieces, policy
briefs, and white papers, and how they’re perceived in a
career-development trajectory.
EFA: I review hundreds of CVs every year in my aca-
demic affairs role, and I think what matters relates to
the theme that Glenn mentioned about endowed chairs.
Institutions have a lot of specific rules, and some rules
are universal, but you need to ask questions about your
institution, the criteria for advancement. At my institu-
tion, we have five titles, and each title has slightly differ-
ent expectations, so you need to know by what measure
you will be judged. For some of our titles, pieces like op-
eds or editorials, especially in professional journals, can
be very important, although, usually, you have to be
standing on a body of accomplishment to be asked to
write an editorial, which is a more of a thought piece.
Most institutions want original scholarship, whether it’s
a case series which demonstrates some new clinical en-
tity, or the more traditional research publication. In our
CV structure, we have peer-reviewed publications and
then other publications.
GF: I would emphasize that there’s what you do which is
going to be considered for tenure, and there’s what you
want to do in your career, and op-eds are a great way to call
attention to important policy issues. I’ve published a few,
and some of them have really had some nice impact, and in
ways I didn’t anticipate. So I would encourage you to think
about them. There is one big caveat: you need to be careful
about your affiliation when you publish your op-ed. We
had some issues at a former institution about people listing
their affiliation at a state university, and, essentially, the
op-ed potentially coming across as a “state-sanctioned”
political viewpoint. That can cause a lot of trouble, and in-
stitutions may be very explicit about prohibiting this. There
are ways to work around it. You can list yourself simply as
“a pediatrician,” or if you have a hospital affiliation and your
hospital is comfortable with it, you can list the hospital
affiliation, but you really have to vet what you can put
down, because it is a form of lobbying in some states
universities, and can actually invoke some legal issues.
There’s a fixed part of the promotion/tenure process
where there’s a committee, and they’re going to have
their criteria, and that process may not necessarily
change, but the part that you may not know about is, it
usually varies from institution to institution, but your
division chief is the one who puts you up for promotion,
so you need to work with your division chief to put to-
gether your package and make the arguments on your
behalf. Therefore, if you’re saying that you’re a policy ex-
pert, op-eds and issue briefs would be really important,
and maybe something that the promotion/tenure com-
mittee, even though they don’t normally weigh heavily,
may say, “okay, in their realm, this is important.” I don’t
think there’s any single correct answer to your qeustion,
but as Elena was saying, there are some traditional prod-
ucts that people look at and sometimes will weigh more
heavily.
LP: If you take out the whole issue of tenure and pro-
motion, just in terms of the research that you’re doing,
it depends. These non-academic pieces can be both pro-
fessional journals or in the lay media, and if you’re an
advocate and working in the community, having your
name in the press is actually really helpful, because it
gives you name and credibility in the community. It
might open up some doors in the community. In terms
of the academic stuff, let’s say it’s a non-peer-reviewed
piece. When you get evaluated, you get evaluated on
your research, your education, your clinical, but there’s
also something called professional leadership. So if you
do an editorial or something that may not be peer-
reviewed, but shows that you’re a thought leader, that
goes into you being evaluated in terms of your profes-
sional leadership.
FM: I would just add that this comes back to the issue
of what does it take to get promoted at your school in
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your line. So your homework is to figure this out, be-
cause it may be that these kinds of things are not useful
for your promotion. We want to leave you with the idea
that it is important to know, and be conscious about
whether an activity is going to help you or not. This is
important because a lot of people do activities that don’t
always help them. So, when you go back to your institu-
tion and figure out what exactly it takes for you to get
promoted, it should be your informed judgement of
where you think an activity has academic value. Finally,
there are a lot of things happening in communities right
now that you may want to speak about, and that’s great,
but it may not necessarily be part of your CV.
Racism and discrimination in academic medicine and how
to address them
Christopher Russell: We wanted to hear a little bit
about if any of you on the panel had experienced racial
or other types of discrimination in your career and how
you dealt with it. Do you think that racial and other
biases are different in the workplace now, better, or
different, and what we can do to change it?
EFA: I’ve experienced gender discrimination. When I
was interviewing for a job, I was pregnant with my sec-
ond son, and the interviewer, an older man, knew that I
was pregnant. He told me something like, “it’s very diffi-
cult to be a mother and an academic.” He didn’t say, “I
don’t know if you can succeed,” but that was, of course,
right there, and I was rendered speechless, because I had
not raised the issue of my pregnancy. I didn’t know what
to do, because I thought, I’m probably not going to get
this job, since he raised the issue, and I didn’t tell him,
“you have no right to say that.” I was very upset, and
wrote a follow-up letter that didn’t directly address the
pregnancy, but stated that I was aware of the expecta-
tions, and reiterated my qualifications and interest. I got
the job, and we can call that a happy ending. But what if
he hadn’t said it, but had the thought and had acted on
it? Now, with more publicity about the laws and rules
and the antidiscrimination clauses, I hope that none of
you hears anything like that. We now have all kinds of
reporting requirements, and Title IX offices, all of which
can trigger investigations, if that kind of thing ever
happens. Every institution has to have a mechanism to
handle these issues, so, if it happens to you, please
report it to the appropriate person. You can report it
anonymously, but institutions have an obligation to
respond. They are also supposed to educate people
about what you can and cannot ask; however, if you raise
a personal issue, then it’s okay to discuss. For example, if
you ask whether there is a childcare center, you’ve raised
the issue of children. I’m not saying you shouldn’t, but
just understand that, sometimes, these issues can be very
tricky.
FM: In my career, there have been episodes. One was
with a patient early in my career. There was a patient I
had; the mother said, “you know, I don’t want to be
treated by a Mexican doctor.” I said, “fine, let me find
you another doctor,” and felt that the patient was clearly
racist, but, for me, the situation was, why should I carry
her burden of being racist? I said to myself, “well that’s
your problem. I’m concerned about your child and my
job is to do the best for your child, so let’s get you a doc-
tor that you feel comfortable with.” I don’t need to deal
with people that are racist. I always felt that I can’t stop
people from being racist, but I can stop how it affects
me. I go back to what my core values are, which are
treating people fairly and compassionately. For some
people, it’s kind of hard to do, but I also have the core
value of a pediatrician having my primary concern for
the child. So if it was a child abuse issue, I would not
have been flexible, But, in this scenario, it was a child
with asthma, so I was fine with linking her with another
physician, but I think it’s important for me to have
control of the situation. We always try to make our en-
vironment less with the “isms,” such as racism, but it’s
hard to do. We’re not seeing a lot of change in the last
20–30 years, but I do think that we need to figure out
for ourselves, as leaders, how we deal with it, how it
affects us, and how we can help trainees to deal with it.
Whatever we do, we can’t take people’s problems or
their racism and put it on our shoulders. We have
enough issues in our own personal lives. So you have to
find a way to say, “that’s their problem, if they start af-
fecting me or my colleagues, then I need to do some-
thing about it.” Racism and other “isms” are issues that
all of us have to be active in addressing and pushing the
envelope to make sure it doesn’t affect the care of our
patients. But as we do this, we also don’t want to take
on the burden solely by ourselves.
GF: I can relate two experiences. One was personal, in
terms of promotion and tenure, and I want to say that,
these days, it’s more insidious. I don’t think it’s quite as
overt as Dr. Mendoza might have experienced many
years ago, but I think it’s just as intense in terms of the
magnitude. Early on in my career, when I was up for
promotion from Assistant to Associate Professor, I
thought that I had an excellent track record in what, at
that time, was the burgeoning field of disparities. I had
published a fair amount in major journals and had sev-
eral substantial grants and thought that I was worthy of
promotion. It was my fifth year as an assistant professor
and I didn’t get promoted; I didn’t feel I was advocated
for in the process and that my work wasn’t valued. I felt
that it was due to some racism, and so I subsequently
vigorously advocated for myself, including pointedly
mentioning that maybe I didn’t get promoted because of
the area (disparities) or my “background” (being Latino).
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And the next year, I did get promoted. So that’s how I
dealt with it, but I’ll never really know for sure what
happened, and it concerned me, particularly because I
believe I was the first minority investigator faculty mem-
ber ever up for promotion in the Department.
And then the other issue is that it is systemic, and done
in such an insidious way that you may not necessarily
think it’s racism or bias. For example, I was at another
institution where they had a faculty conference with all
200 faculty there, and they said, “we need to enhance our
case mix because our profit and our revenues are lacking.
So we’re now going to limit the percent of Medicaid
covered kids that we’ll see.” And, in particular, they were
talking about doing this in clinics that were located in
more affluent neighborhoods. I stood up in the middle of
this faculty conference and said, “this really bothers me.
This is actually sounding like a form of discrimination.” I
then shared the famous MLK quote: “Of all the forms of
inequality, injustice in health care is the most shocking
and inhumane.” People looked astounded, and I actually
got some good feedback later on about it. They backed off
of this “initiative,” but I felt that it was part of a systemic
approach to racism and discrimination against low-
income and minority children. The other thing going on
was that a lot of the undocumented kids were being seen
in federally qualified health centers, and they had chronic
diseases, and they clearly needed specialty care for some
of the most severe conditions, such as renal failure. And
yet, this major children’s’ hospital was making it harder,
just outright refusing to see patients who either didn’t
have insurance or were on Medicaid, so that the primary-
care physicians and pediatric residents at the federally
qualified health center had to essentially be the subspecial-
ists. I raised this a number of times and didn’t get all that
much traction. But sometimes, it’s essential for you to be
the voice to alert people to the fact that what they’re
proposing or doing may ostensibly sound like it’s helping
in terms of the finances, but it’s actually not a good
population-health approach and can easily be seen as
systemic, systematic racism and bias.
FM: Let me just add one more thing. It’s important for
you, at your stage, to find somebody that you can talk to
about these things, too. The hardest thing is just to have
it internally. It may be your colleagues, it may be senior
deans, but this is going to happen, and you just need to
make sure that you have somebody to talk to. And, at
the end of day, the thing that we want to do through this
RAPID conference is create resiliency and success, as
these are burdens that can really hinder things. And if
you can find a way to deal with it internally, but also
externally with colleagues and the appropriate adminis-
trators, that’s a real positive thing. It’s a great buffer.
GF: I want to echo what Fernando said, too, because
there are studies, putting on my scientist hat, really
impressive studies by Jim Collins about maternal lifetime
exposure to interpersonal racism, and that it’s strongly
associated with very low birth weight in infants and pre-
term delivery, but active coping behaviors weakened this
relationship. What Fernando brought up is important.
You’re going to experience racism and discrimination,
and you may already have been victimized by them, so
you need to talk to your colleagues and to a trusted
mentor so that this doesn’t end up taking a toll on you,
but rather allows you to be resilient and to do something
positive in response.
Coping with isolation as a minority faculty member
Kimberly Reynolds: As a follow-up question, how do
you deal with some of the isolation that’s been shown in
the literature that minority faculty members feel? There’s
the pressure to serve and to be the “token,” but there’s
also a lot of, just, “isolation.” Have any of you experi-
enced that, and how do you deal with it?
FM: When I became faculty in 1981, I was the only
minority faculty, but there were people who were not
minority that were very supportive, so you’ve got your
friends, the people who are always there for you, and
then as we grew, other people, minority folk, came onto
the faculty. You have to look and see, where is your so-
cial support? Social support is probably one of the stron-
gest things to fight and buffer stress, and, for me, it was
that kind of process, finding people both internal and
external to the medical school. I was the only minority
in the whole pediatrics department, so I looked through-
out the med school and looked outside. This resulted in
my main mentor being an anthropologist, a Latino. It’s
extra work, but the reward is having somebody that you
can connect with.
Juan Espinoza: Also as a follow-up, my dad was a
career NIH scientist. He was there for 20 years, and he
always told me, from the time that I was in high school,
do not apply for anything that says “minority” in it,
because it may change the way people perceive you. It’s
something that I’ve struggled with in my career, having
that as the viewpoint. Looking back, what was the role
of those kinds of opportunities or programs in your car-
eer? How do they reflect on us, is there an insidious
underside to some of these things, and how does that
balance out long-term?
FM: My career at Stanford has been one of supporting
minorities for 33 years. And I’ve had faculty say, “I don’t
want to be considered minority faculty.” Okay. I don’t
see you as minority faculty. But here’s the thing: as long
as we perceive ourselves to be less, we’re going to be
less. I did an early pipeline program bringing students to
Stanford before they started medical school. I said to
them, “I want you to be faculty, and you are going to be
faculty here. We want you to be a part of our Stanford
Flores et al. International Journal for Equity in Health  (2016) 15:201 Page 7 of 10
family.” We have now a number of minority alumni who
are faculty at Stanford and other medical schools across
the country. This happened partially because we believed
that they could become faculty, creating this expectation
in their minds. In two years, this country will have half
of all the kids being minorities. Are we still going to be-
lieve that minorities can’t become faculty? In 20 years,
half of the US population will be minorities. We need to
show that it’s not just being successful, it’s showing other
people, “I’m a minority and I’m successful.” And that, at
the end of day, is how things change.
You all can be extremely successful, but you still have
to be who you are. Moreover, this helps me show stu-
dents in the pipeline, here’s somebody that looks like
you, and look what they’ve done. And I know, it’s easier,
perhaps, not to be a “minority,” and if you don’t look a
minority then it’s easier, right? But I think that that’s part
of the issue; we need to say who we are and what we
come from so that we can make an impression. And it’s
not just really the impression for the people that don’t
believe, it’s the impression for us, too. You’ve been
impressed by those of us here, right? Hopefully, that
makes you think that you can do it, because you can.
But at the end of day, it’s going to have to be that kind
of effort, the country is fighting stereotypes right now,
this is what you see now and will see for the next
10 years, 20 years. We had civil rights, now we have
something different: we have human rights, the ability to
achieve your fullest potential. We have to believe this
country is equal throughout. And that, at the end of day,
is not going to be something that I do, because I’m at
the tail end of my career. It’s going to be you guys.
JM: I wanted to add something. In talking about spe-
cific RFAs [requests for applications] and NIH grant op-
portunities for minorities, I would say, seize those
opportunities, because the reason they exist is because
whatever “normal” opportunities there are haven’t been
doing a good job of being inclusive and hitting popula-
tions and topics that are important for minorities. And if
you propose excellent science, and, of course, you get
excellent results, no one should look on it askance. You
are moving the field forward in a way that couldn’t or
didn’t happen in the past, so seize those opportunities.
LP: White privilege has been going on for so long. Ba-
sically, what I see these programs doing is trying to bal-
ance out the issues that we’ve had for generations and
generations of white privilege. So I see nothing wrong
with it and I would seize the opportunities as well.
GF: I would encourage you to stand up and be
counted. There’s some risk involved. There are the stud-
ies that show that if you submit an application for a job
and your name is Shamika instead of Buffie, you’re less
likely to get a job interview, and, obviously, if you have a
Latino-sounding name, I would assume the same
principal is in effect. But, one of the most cogent things
I’ve ever heard was from a medical student who was
interviewing at a residency program. She said to me,
“I’ve looked at the faces of the residents and I counted
how many minorities there were, and there weren’t a
lot.” And we do that: we look at an institution and say, is
this institution going to be diversity friendly? The only
way to be able to determine that sometimes is to look at
statistics. And so, if you’re not allowing yourself to be
counted because you’re afraid of being discriminated
against, which is a true and valid fear, in a sense, you’re
not empowering yourselves by saying, “I’m being
counted, I’ve established a beachhead here, I’m here for
you,” hopefully, in the way that we’re being here for you
today, because you’ll be that island in the sea of other-
wise whiteness that allows people to say, “I have a re-
source, I have a mentor, I have an advocate, or I have a
sponsor.” So, there is risk involved, but I think you will
benefit yourself and you’ll benefit a lot of people who
come after you by having the courage to say, “yes, I am a
minority and I’m proud of it!”
How best to mentor the next generation of academic
physicians
Kenya Parks: What can we do to better in the next gen-
eration of physicians as we mentor? How can we ad-
vance in a better way, because, given the statistics on
individuals entering medical schools, in some ways,
we’ve gone backwards. So as we usher in this new gener-
ation of physicians, what are our roles, what would you
suggest that we do in our capacities to advance the
cause?
FM: I think you have to tell people that they belong in
medicine. We’re told in many ways that we don’t belong.
You have to reinforce the idea that they do belong, that
they bring with them the capacity to succeed. They bring
with them the talent the healthcare system needs, and
they bring with them the kinds of things that will then
eventually make this country better. It’s that easy. In
California, half of all the kids are Latino. If they’re not
graduating from high school, they’re not going to col-
lege. In that scenario, what is the economic future for
California? The Urban Institute has estimated that every
child that lives in poverty costs the country $38,000. As
a result of the number of children in poverty, we lose a
half a trillion dollars per year. Think about what that
says about our society. There are countries around the
world poorer than ours that do better with their kids.
So, to me, it makes economic sense to get the most out
of everybody we have in the country. Moreover, we’ve
got to help each other achieve this goal. When some-
body stands up to act on this issue, you can’t just keep
sitting down. You’ve got to stand up with them.
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EFA: I would add that these things also impact who
we hire as faculty members, who we hire as staff, who
we bring on for residents and medical students, but
none of us talking about the big picture in terms of the
people we care for, and all of that is also important. If
you are asked to serve on a search committee, you could
react by saying that you don’t have time, but I would en-
courage you to consider it an opportunity. When you
participate on a search committee, you have a voice in
the selection of a leader or a colleague. That’s how we
start changing institutions. Some of it is big picture, and
you can have a significant impact if you’re a leader. Re-
gardless of our title or our role, we have opportunities
every day to think about and to advance these issues,
but it will involve work, it will involve time, so it’s not
going to happen just by sitting back and thinking that
it’s important. It’s going to require that you invest in it,
but I think that all of those ways ultimately can lead to
institutional change.
Conclusions
In conclusion, racial/ethnic minority young investigators
in academic pediatrics attending the annual RAPID
conference identified six hot topics on the most useful
faculty and career-development issues for ensuring
academic success and optimal career development for
young clinician-investigators in academic medicine from
diverse backgrounds. These six topics included: negotiat-
ing for protected research time, career trajectories as
academic institutions move away from an emphasis on
tenure-track positions, how “non-academic” products fit
into career development, racism and discrimination in
academic medicine and how to address them, coping with
isolation as a minority faculty member, and how best to
mentor the next generation of academic physicians.
Senior RAPID conference leadership provided responses
to young minority investigators’ questions about these
topics. Advice to young minority investigators on negoti-
ating for protected research time includes identifying in
advance what is specifically needed for success, under-
standing the priorities of the division chief, emphasizing
rationale and return on investment, and demonstrating
positive research outcomes with research effort provided
to date. Key counsel on career trajectories as academic
institutions move away from an emphasis on tenure-track
positions includes demonstrating faculty contributions in
all academic mission areas (clinical, education, scholar-
ship, and service), understanding the changing nature of
tenure, and comprehending how money flows at your
institution. Guidance on how “non-academic” products fit
into career development includes understanding the spe-
cific institutional criteria for advancement, appreciating
the distinction between fulfilling institutional expectations
and personal career goals, and the importance of op-eds
in advancing advocacy.
Regarding racism and discrimination in academic
medicine and how to address them, senior conference
leadership recounted specific experiences with racism
and gender discrimination, and advised reporting such
incidents to the appropriate institutional leaders and of-
fices, making sure to protect yourself emotionally when
you are subjected to racism or discrimination, vigorously
confronting racism and discrimination when they are
encountered, and discussing and working through these
issues with mentors and peers. On the subject of coping
with isolation as a minority faculty member, senior con-
ference leadership recommend identifying social support
both within and across departments and schools at your
institution, and being proud of one’s identity as a minor-
ity (rather than hiding it) in order to be a role model
and resource. Concerning how best to mentor the next
generation of academic physicians, senior conference
leadership advise reinforcing for minority faculty a sense
of belonging and the capacity to succeed, and taking on
leadership opportunities that have the potential to ad-
vance the causes of diversity and institutional change for
the better for minority faculty.
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